Event Date:
09/18/2020
Description:
Speaker: Rajat Mukherjee, PhD (Cytel)
Title: A Bayesian Sequential Design for COVID-19 Vaccine Trials
Abstract: We present a Bayesian design for studying the efficacy of BCG and a competitor TB vaccine in preventing symptomatic COVID-19 infections in health care workers. The proposed design offers flexibility of sample size by having regular interim looks. At each interim look, the predictive power with the current cohort is computed and decision to stop enrollment or continue to the next interim is made based on the predictive power reaching a certain pre-specified threshold. Once the predictive power crosses this threshold, the study enter a close-out phase and the final analysis is conducted once all recruited subjects have completed the minimal follow-up time. The design can also allow for dropping a non-efficacious arm and for futility stopping. Design parameters are all pre-specified and determined via evaluation of the frequentist operating characteristics based on simulations.
Join Zoom Meeting
https://diaglobal.zoom.us/j/2203599026
Meeting ID: 220 359 9026
One tap mobile
+16468769923,,2203599026# US (New York)
+16699006833,,2203599026# US (San Jose)
Dial by your location
+1 646 876 9923 US (New York)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 301 715 8592 US (Germantown)
+1 312 626 6799 US (Chicago)
+1 346 248 7799 US (Houston)
855 880 1246 US Toll-free
877 853 5257 US Toll-free
Meeting ID: 220 359 9026
Find your local number: https://diaglobal.zoom.us/u/tdzNsDvQ
Join by Skype for Business
https://diaglobal.zoom.us/skype/2203599026